Skip to main content
Clinical Trials/TCTR20211022001
TCTR20211022001
Completed
Not Applicable

Genetic study to identify genetic variants which affect clinical severity in Thai patients with beta thalassemia hemoglobin E

Siriraj Hospital0 sites338 target enrollmentOctober 22, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
clinical variation in patients with beta thalassemia Hb E disease
Sponsor
Siriraj Hospital
Enrollment
338
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 22, 2021
End Date
November 30, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Thai patients with beta thalassemia hemoglobin E aged over 17 who give consent to collect personal data and DNA
  • 2\.Thai children with beta thalassemia hemoglobin E aged over 4 whose parents give consent to collect personal data and DNA
  • 3\.Thalassemia diagnosed by hemoglobin typing or polymerase chain reaction or has been reported in medical record

Exclusion Criteria

  • 1\.Patients with beta thalassemia hemoglobin E are treated by drugs that affect percentage of hemoglobin F such as hydroxyurea
  • 2\.Patients with beta thalassemia hemoglobin E having other diseases which can cause anemia
  • 3\.Patients receiving last red blood cell transfusion less than 2 weeks before the start of the study
  • 4\.Patients with beta thalassemia hemoglobin E with moderate clinical severity
  • 5\.Patients refusing to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials